Patents by Inventor Aaron Chesnut

Aaron Chesnut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATIONS COMPRISING NALTREXONE AND/OR BUPROPION
    Publication number: 20260102354
    Abstract: Described are pharmaceutical formulations comprising naltrexone and/or bupropion. Such pharmaceutical formulations can comprise extended-release, multilayer beads. Also described are methods of administering such formulations, such as for the treatment of overweight or obesity.
    Type: Application
    Filed: May 19, 2025
    Publication date: April 16, 2026
    Applicant: Nalpropion Pharmaceuticals LLC
    Inventors: Rob Churchill, Aaron Chesnut
  • Pharmaceutical formulations comprising naltrexone and/or bupropion
    Patent number: 12599563
    Abstract: Described are pharmaceutical formulations comprising naltrexone and/or bupropion. Such pharmaceutical formulations can comprise extended-release, multilayer beads. Also described are methods of administering such formulations, such as for the treatment of overweight or obesity.
    Type: Grant
    Filed: May 19, 2025
    Date of Patent: April 14, 2026
    Assignee: Nalpropion Pharmaceuticals LLC
    Inventors: Rob Churchill, Aaron Chesnut